| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/22/2009 | US20090022776 Composition and method for treatment and prevention of restenosis |
| 01/22/2009 | US20090022753 Surface proteins of streptococcus pyogenes |
| 01/22/2009 | US20090022748 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| 01/22/2009 | US20090022747 B7-h3 and b7-h4, novel immunoregulatory molecules |
| 01/22/2009 | US20090022737 Aldos as modifiers of the igf pathway and methods of use |
| 01/22/2009 | US20090022730 Methods and compositions for assessing acute rejection |
| 01/22/2009 | US20090022725 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022711 Methods of modulating cell death based on the bit-1/aes regulatory pathway |
| 01/22/2009 | US20090022710 Nuclear factor of activated t cells receptor |
| 01/22/2009 | US20090022709 Control of sorbose utilization genes and uses thereof |
| 01/22/2009 | US20090022708 Trefoil Factors and Methods of Treating Proliferation Disorders Using Same |
| 01/22/2009 | US20090022703 Treating age-related macular degeneration associated with a loss of elastic fibers by administering a LOXL1 polypeptide that can catalyze the crosslinking of elastin |
| 01/22/2009 | US20090022692 Therapeutic agent for heart disease using map kinase tnni3k |
| 01/22/2009 | US20090022685 Orthotopic, controllable, and genetically tractable non-human animal model for cancer |
| 01/22/2009 | US20090022677 Methods for identifying treatments that treat and/or prevent UV irradiation induced photoaging |
| 01/22/2009 | US20090022667 METHODS OF TREATING COGNITIVE DISORDERS BY INHIBITION OF Gpr12 |
| 01/22/2009 | US20090022666 Methods and systems relating to mitochondrial DNA information |
| 01/22/2009 | US20090020502 Biosensor and method of making |
| 01/22/2009 | DE112006003813T5 Wasserlösliche Konjugate zur elektrochemischen Detektion Water-soluble conjugates for electrochemical detection |
| 01/22/2009 | DE102007032799A1 New sugar-containing polypyridine metal complexes e.g. useful as fluorescence markers in biological systems or for treating abnormal cells |
| 01/22/2009 | DE102007027414B3 Mikro- und Nanofluidsystem zur dynamischen Strukturanalyse von linearen Makromolekülen und Anwendungen davon Micro- and nano-fluid system for dynamic structural analysis of linear macromolecules and applications thereof |
| 01/22/2009 | CA2696431A1 Method for generating aptamers with improved off-rates |
| 01/22/2009 | CA2694545A1 Arrays, substrates, devices, methods and systems for detecting target molecules |
| 01/22/2009 | CA2693974A1 Methods for quantitating small rna molecules |
| 01/22/2009 | CA2693973A1 Compositions and methods to detect tmprss2/erg transcript variants in prostate cancer |
| 01/22/2009 | CA2693805A1 Nicking and extension amplification reaction for the exponential amplification of nucleic acids |
| 01/22/2009 | CA2693768A1 Ovine identification method |
| 01/22/2009 | CA2693453A1 Multiplexed analyses of test samples |
| 01/22/2009 | CA2693449A1 Nucleic acid sequences for the amplification and detection of respiratory viruses |
| 01/22/2009 | CA2693448A1 Improved selex and photoselex |
| 01/22/2009 | CA2693153A1 Target enzyme in the treatment of acne |
| 01/22/2009 | CA2693059A1 Method and apparatus using electric field for improved biological assays |
| 01/22/2009 | CA2693031A1 Differential expression of micrornas in nonfailing versus failing human hearts |
| 01/22/2009 | CA2693013A1 Drug selection for lung cancer therapy using antibody-based arrays |
| 01/22/2009 | CA2692882A1 Ultrasensitive detection of target using target-ready particles |
| 01/22/2009 | CA2692784A1 Compositions and methods for diagnosing and assessing inflammatory myopathies |
| 01/22/2009 | CA2692710A1 Genetic basis for improved milling performance |
| 01/22/2009 | CA2691847A1 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 01/22/2009 | CA2691127A1 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/22/2009 | CA2687375A1 Primers and probes for the detection of streptococcus pneumoniae |
| 01/21/2009 | EP2017621A1 Phosphorylation of histone H3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/21/2009 | EP2017620A2 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (DPP1) |
| 01/21/2009 | EP2017607A1 Biosensor |
| 01/21/2009 | EP2017357A1 DNA diagnostics based on mass spectrometry |
| 01/21/2009 | EP2017356A2 Tagged oliggonucleotides and their use in nucleic acid amplification methods |
| 01/21/2009 | EP2017355A1 Gene associated with arteriosclerotic disease, and use thereof |
| 01/21/2009 | EP2017354A1 Detection and/or quantification of target molecules on a solid support |
| 01/21/2009 | EP2017353A1 Method of detecting bias in enzyme electrode measurements |
| 01/21/2009 | EP2017352A1 CM sensor with covalent-bound enzyme |
| 01/21/2009 | EP2017351A1 Combined method and kit for the sequential measurement of (1) the enzymatically active fraction and (2) the total amount of an enzyme |
| 01/21/2009 | EP2017350A1 Electrochemical sensor with covalent-bound enzyme |
| 01/21/2009 | EP2017340A1 Positive controls for expression modulating experiments |
| 01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
| 01/21/2009 | EP2017336A1 Marker for selecting aphanomyces cochlioides-resistant variety and selection method therefor |
| 01/21/2009 | EP2017335A1 Mutated Abl kinase domains |
| 01/21/2009 | EP2017333A1 Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell |
| 01/21/2009 | EP2016952A2 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 01/21/2009 | EP2016951A1 Polypeptides homologous to VEGF and BMP1 |
| 01/21/2009 | EP2016611A2 Portable reactor for real-time nucleic acid amplification and detection |
| 01/21/2009 | EP2016422A1 Detection of venous thromboembolic diseases by measurement of d-dimers and soluble fibrin levels |
| 01/21/2009 | EP2016417A1 Biomarkers for endometrial proliferation |
| 01/21/2009 | EP2016410A1 Method for the coupled enzyme immunochemical assay of analytes by means of endogenous calibrators |
| 01/21/2009 | EP2016405A2 Methods and apparatus for identifying disease status using biomarkers |
| 01/21/2009 | EP2016199A2 100% sequence identity detection methods for variable genomes |
| 01/21/2009 | EP2016198A2 Hla alleles associated with adverse drug reactions and methods for detecting such |
| 01/21/2009 | EP2016197A2 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 01/21/2009 | EP2016196A2 Aqp5 polymorphism |
| 01/21/2009 | EP2016194A2 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 01/21/2009 | EP2016193A2 Device for quantification of radioisotope concentrations in a micro-fluidic platform |
| 01/21/2009 | EP2016192A2 Microorganisms detection and enumeration method |
| 01/21/2009 | EP2016191A2 Novel fetal markers for prenatal diagnosis and monitoring |
| 01/21/2009 | EP2016190A2 New fetal methylation markers |
| 01/21/2009 | EP2016189A2 Droplet-based pyrosequencing |
| 01/21/2009 | EP2016188A1 Methods for detection of methylated dna |
| 01/21/2009 | EP2016186A2 Methods and apparatus for sequential amplification reactions |
| 01/21/2009 | EP2016091A2 Droplet-based biochemistry |
| 01/21/2009 | EP2016089A1 Gene defects and mutant alk kinase in human solid tumors |
| 01/21/2009 | EP2015782A2 Compositions and methods for modulating gene expression |
| 01/21/2009 | EP2015741A2 Histone deacetylase inhibitors for the treatment of neurodegeneration |
| 01/21/2009 | EP1969141A4 Assay for detection of telomerase activity |
| 01/21/2009 | EP1896617A4 Multiplexed amplification of short nucleic acids |
| 01/21/2009 | EP1888781A4 Liquid crystal based analyte detection |
| 01/21/2009 | EP1830632B1 Method for obtaining a triploid interspecific hybrid sea bass |
| 01/21/2009 | EP1774041A4 Compositions and methods for preparation of nucleic acids from microbial samples |
| 01/21/2009 | EP1774015A4 Detection of nucleic acids to assess risk for bovine spongiform encephalopathy |
| 01/21/2009 | EP1745118A4 Smart combinatorial operando spectroscopy catalytic system |
| 01/21/2009 | EP1718761B1 Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators |
| 01/21/2009 | EP1699282A4 Compositions and methods for detecting reverse transciptase in a sample |
| 01/21/2009 | EP1506228B1 Role of p62 in aging-related disease |
| 01/21/2009 | EP1495330B1 Method of identifying transmembrane protein-interacting compounds |
| 01/21/2009 | EP1490691B1 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies |
| 01/21/2009 | EP1414945B1 Cell culture method for obtaining prostate-like acini |
| 01/21/2009 | EP1402257B1 Proteins in diabetes proteome analysis |
| 01/21/2009 | EP1328810B1 Three dimensional format biochip |
| 01/21/2009 | EP1307588B1 Method for diagnosing or determining a risk for psychosis comprising determining an heterozygous mutation of methylenetetrahydrofolate reductase (MTHFR) |
| 01/21/2009 | EP1307585B1 Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites |
| 01/21/2009 | EP1301627B1 Improved detection signal and capture in dipstick assays |
| 01/21/2009 | EP1294906B1 Whole-body optical imaging of gene expression and uses thereof |
| 01/21/2009 | EP1234880B1 Novel protein tab2 |